Skip to main content

Home
Specialties
Resources

Search Videos and More

search

Channel Categories

Breast Cancer (6)
Cancer Screening and Survivorship (4)
Cell Therapy (19)
Clinical Trials (16)
Gastrointestinal Cancer (7)
Genitourinary Cancer (6)
Gynecologic Oncology (6)
Head and Neck Cancer (6)
Hematologic Oncology (79)
Immunotherapy (13)
Neuro-Oncology (4)
Pediatric Hematology/Oncology (7)
Primary Care (5)
Radiation Oncology (5)
Skin Cancer (5)
Thoracic Cancer (8)
Young Adult Malignancies (2)

Types

News (44)
Symposium (3)
Video Asset (32)

Showing 1 - 12 of 79 results

Previous| 1 | 2 | 3 ...7 |Next

Meet the Team: Maksim Liaukovich, MD

Meet the Team: Maksim Liaukovich, MD

Roswell Park at ASH 2025

Roswell Park at ASH 2025

Biomarker-Driven “Umbrella” Study Matches AML, MDS Patients with Specific Clinical Trials

Biomarker-Driven “Umbrella” Study Matches AML, MDS Patients with Specific Clinical Trials

Roswell Park Experts Share Latest Hematology Research at 67th ASH Annual Meeting

Roswell Park Experts Share Latest Hematology Research at 67th ASH Annual Meeting

Roswell Park Experts Host Symposium to Reconnect the “Meaning in Medicine”

Roswell Park Experts Host Symposium to Reconnect the “Meaning in Medicine”

Join Roswell Park Revolutionaries for Cell Therapy Symposium at ASH

Join Roswell Park Revolutionaries for Cell Therapy Symposium at ASH

Meet the Team: Chelsea Peterson, DO

Meet the Team: Chelsea Peterson, DO

Myeloma Experts Uncover Key Role for Neutrophils, Potential New Treatment Strategy

Myeloma Experts Uncover Key Role for Neutrophils, Potential New Treatment Strategy

Final Landmark Clinical Trial Data Demonstrates Deep, Durable Responses to Menin Inhibition in Acute Leukemia Patients

Final Landmark Clinical Trial Data Demonstrates Deep, Durable Responses to Menin Inhibition in Acute Leukemia Patients

$Phase 1 Clinical Trial Offers FDA Fast-Tracked Drug for Relapsed/Refractory AML and MDS$ News

Phase 1 Clinical Trial Offers FDA Fast-Tracked Drug for Relapsed/Refractory AML and MDS

Clinical CAR T-cell Trial for Multiple Myeloma Suggests Possible “Cure”

Clinical CAR T-cell Trial for Multiple Myeloma Suggests Possible “Cure”

Cellular Therapies Leading to New Treatment Options for Lymphoma Patients

Cellular Therapies Leading to New Treatment Options for Lymphoma Patients

Showing 1 - 12 of 79 results

Previous| 1 | 2 | 3 ...7 |Next

BROADCASTMED
BroadcastMed Privacy Policy

Medical Disclaimer